Survey of adults in decentralized clinical trials
Official title: A Longitudinal, Multicenter Survey of Adult Participants Enrolled in Decentralized Clinical Trials
Run by Nantes University Hospital · NCT06751641 · Data updated 2026-11-12
This study is trying to see if adults in regular clinical trials would be open to joining decentralized trials that let them participate from home using digital tools.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Status | Recruiting |
| Started | April 5, 2024 |
| Main results expected | June 5, 2025 |
| Study ends | June 5, 2025 |
| Registry record updated | January 16, 2025 |
| Trial ID | NCT06751641 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this survey are adults enrolled in interventional clinical trials evaluating a drug who are willing to share their experiences.
✕Probably not a fit
Patients who are not currently enrolled in a clinical trial or those participating in trials with non-translatable procedures may not benefit from this survey.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This survey evaluates the willingness of adults currently enrolled in traditional clinical trials to participate in decentralized clinical trials (DCTs). DCTs utilize digital tools such as telemedicine and wearable devices to reduce the burden on participants by allowing them to engage in trial activities from home. The study aims to gather insights from participants about their experiences and perceptions regarding the feasibility and benefits of incorporating decentralized elements into clinical trials. By understanding participant perspectives, the research seeks to enhance recruitment and retention in future DCTs.
Why it matters
Potential benefit: If successful, this study could lead to improved accessibility and participant engagement in clinical trials, ultimately enhancing patient outcomes.
How similar studies have gone: While decentralized clinical trials are a growing area of interest, this survey specifically aims to gather insights from participants in traditional trials, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults. Patients or healthy volunteers, ambulatory, enrolled in an interventional clinical trial evaluating a drug and receiving the trial treatment(s) either at the investigative site and/or at their place of residence. Exclusion Criteria: Individuals who have not expressed their non-opposition to participating in the survey. Individuals participating in a clinical trial with procedures that are not deemed translatable to decentralized procedures.
Where it's running
-
CHU Nantes
Nantes, France Recruiting
Study contacts
- Principal investigator: Laurent Flet, PharmD — Nantes University Hospital
- Study coordinator: Laurent Flet, Pharm D
- Email: laurent.flet@chu-nantes.fr
- Phone: +33 2 40 08 41 54
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.